Moldova vs Netherlands: Cervical cancer screening coverage in Europe
Moldova
60.1%
in 2024
Netherlands
54.4%
in 2024
Moldova rank
16th
Netherlands rank
19th
Cervical cancer screening coverage in Europe over time
- Moldova
- Netherlands
How they compare
Moldova currently reports 60.1% against 54.4% in Netherlands, a difference of 5.7%.
That makes Moldova's figure about 1.1 times Netherlands's.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was Moldova ahead.
Moldova ranks 16th and Netherlands ranks 19th of 29 countries.
Moldova has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Moldova | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.6% | 56.6% | 6.0% | Moldova |
| 2020s | 57.1% | 50.7% | 6.4% | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cervical cancer screening coverage in europe, Moldova or Netherlands?
- Moldova, at 60.1% against 54.4% in Netherlands as of 2024.
- What is the difference in cervical cancer screening coverage in europe between Moldova and Netherlands?
- 5.7%, with Moldova ahead.
- How many years of comparable data are there for Moldova and Netherlands?
- 8 years are reported by both, from 2017 to 2024.
- How do Moldova and Netherlands rank globally for cervical cancer screening coverage in europe?
- Moldova ranks 16th and Netherlands ranks 19th of 29 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Cervical cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 20 to 69 years who have been screened for cervical cancer within the previous 3 years.